March 5, 2015: Merck told workers at newly acquired Cubist Pharmaceuticals Thursday that it will totally eliminate the company's 120-employee drug discovery department in Lexington, Mass.
March 5, 2015: Dublin, Ireland-based Shire filed a Worker Adjustment and Retraining Notification Act (WARN) with the Pennsylvania Department of Labor and Industry yesterday indicating about 600 layoffs by April 1.
March 5, 2015: Chicago-based AbbVie announced today that it is acquiring Sunnyvale, Calif.-based Pharmacyclics. AbbVie will pay $261.25 per share in a mix of cash and equity for a total of about $21B. “The acquisition of Pharmacyclics is a strategically compelling opportunity,” said Richard Gonzalez.
March 5, 2015: The FDA approved Bristol-Myers Squibb’s Opdivo injection for treatment of patients with metastatic squamous non-small cell lung cancer (NSCLC) with progression on or after platinum-based chemotherapy, the company announced Thursday.